White Papers

  1. 4 New Approvals In Q3 Across Gene, Cell, RNA Therapies 11/13/2025

    Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.

  2. Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025) 11/7/2025

    Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.

  3. The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection 11/7/2025

    A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.

  4. The Complexities Of Effective Patient Retention In Clinical Trials 11/7/2025

    Identifying and enrolling the right-fit patients from the outset is essential, but so is implementing comprehensive retention strategies that prioritize patient comfort, trust, and ongoing engagement.

  5. Empowering Mid-Size Pharma Companies With Integrated Drug Development, Regulatory Strategy, And AI Innovation 10/23/2025

    A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy.

  6. Designing More Precise Clinical Trials Using AI-Driven Analytics 10/20/2025

    Clinical trials face staggering failure rates and inefficiencies. Discover how AI and real-world evidence streamline patient recruitment and trial design to help reshape the future of clinical research.

  7. What Is ICH GCP, And How Does It Impact Clinical Planning? 10/20/2025

    The updated ICH GCP guideline modernizes clinical trial standards, aligning with today’s technologies to enhance participant safety, data integrity, and risk-based trial design.

  8. Clinical Trial Disclosure Noncompliance: What Is Its Impact On Pharma M&As? 10/20/2025

    Noncompliance with clinical trial disclosure regulations can jeopardize M&A deals. Understanding FDA and SEC requirements is critical to avoid red flags during due diligence.

  9. Challenges, Opportunities For Recruitment In The Digital Age 10/20/2025

    Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.

  10. Streamlining Patient Recruitment With AI–Driven Site Identification 10/20/2025

    This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.